Zhongshan Latterson Biotechnology Co., Limitado.

Otros productos de venta caliente (Polvo crudo)

» Otros productos de venta caliente (Polvo crudo)

  • Powder Treatment Of Alzheimer’s Disease 99.38% Purity Rivastigmine Tartrate

    CATEGORÍA Y ETIQUETAS:
    Otros productos de venta caliente (Polvo crudo)
    Número de modelo : 129101-54-8
    Certificación : GMP, SGS , YO ASI 9001:2008 , COMESTIBLE SEGÚN LA LEY JUDÍA
    Lugar de origen : porcelana
    MOQ : 10gramo
    Precio : Negociable ( Descuentos para pedidos grandes )
    Términos de pago : Western Union, MoneyGram, Transferencia bancaria, Bitcoin
    Capacidad de suministro : 100 kg/mes
    El tiempo de entrega : Dentro de 7 Días laborables
    detalles del empaque : Embalaje sigiloso y discreto
    nombre del producto : Rivastigmine Tartrate
    CASO : 129101-54-8
    MF : C18H28N2O8
    MW : 400.42
    EINECS : 1308068-626-2
    Apariencia : White to Off-White Powder
    consulta
    • Especificaciones

    Powder Treatment Of Alzheimer’s Disease 99.38% Purity Rivastigmine Tartrate

    Superioridad
    Zhongshan Latterson Biotechnology Co., Limitado., es una empresa farmacéutica integral, que se especializó en tecnología biofarmacéutica sobre 7 años. La empresa está ubicada en la ciudad de Zhongshan, Provincia de Guangdong , porcelana.
    Nuestra fábrica cubre un área de 33500 metros cuadrados, con un ambiente limpio y un diseño agradable. Hay varios talleres grandes o medianos y un centro de investigación y control de calidad con equipos avanzados.. En el presente, Nuestros principales productos son la serie de esteroides anabólicos., Serie de péptidos, Serie de anestésicos locales. Nuestros productos alcanzan el estándar avanzado del mercado nacional., muchos de los cuales alcanzan el estándar internacional, los certificados contienen: COMESTIBLE SEGÚN LA LEY JUDÍA , YO ASI 9001:2008 , GMP , SGS.

    nombre del producto: Rivastigmine tartrate
    Sinónimos: 3-[(S)-1-(Dimethylamino)ethyl]phenyl N-Ethyl-N-methylcarbamate L-Tartrate N-Ethyl-N-methylcarbamic Acid 3-[(S)-1-(Dimethylamino)ethyl]phenyl Ester L-Tartrate;(S)-3-(1-(diMethylaMino)ethyl)phenyl ethyl(Methyl)carbaMate (2R,3R)-2,3-dihydroxysuccinate;RivastigMine-d6 Hydrogen Tartrate;N-ethyl-N-methyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1);Rivastigmine tartrate (S)-N-Ethyl-3-[(1-dimethylamino)ethyl]-N-methylphenylcarbamate hydrogen tartrate;N-Ethyl-N-methyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester tartrate;Rivastigmine for system suitability;S-Rivastigmine tartrate
    CASO: 129101-54-8
    MF: C18H28N2O8
    MW: 400.42
    EINECS: 1308068-626-2
    Categorías de Producto: Isotopically Labeled Pharmaceutical Reference Standard;intermedios & Productos químicos finos;Neuroquímicos;Productos farmacéuticos;Rivastigmine;Amines;Aromáticos;Chiral Reagents
    Archivo Mol: 129101-54-8.mol
    Rivastigmine tartrate Chemical Properties
    Punto de fusion 123-1250C
    alfa D20 +4.7° (c = 5 in ethanol)
    temperatura de almacenamiento. -20° C Congelador
    solubility H2O: soluble15mg/mL, Solución antibacteriana necesaria en alcohol bencílico de aceite esteroide
    color white to beige
    Safety Information
    RIDADR UN 2811 6.1 / PGII
    RTECS FA9550000
    HazardClass 6.1
    PackingGroup III
    Rivastigmine tartrate Usage And Synthesis
    Pharmacological effects Rivastigmine tartrate is rivastigmine Alzheimer’s disease drugs, rivastigmine is physostigmine derivative by Novartis for the first time successfully developed the trade name Exelon (exelon), a molecule with there carbamate structure, is a kind of amino acid of selective cerebral cholinesterase inhibitor, can also inhibit the acetylcholinesterase and butyrylcholinesterase, cholinergic neurons by delaying the release of acetylcholine degradation and energy promoting cholinergic nerve conduction, can improve cognitive function disorders mediated by cholinergic, thereby improving the cognitive function of Alzheimer’s disease patients. Rivastigmine plasma protein binding is weak, easily through the blood-brain barrier, which has a high degree of brain selectivity. It not only selectively acts on the most easily affected cerebral cortex and hippocampus, but also preferentially inhibits the dominant subtype of AChE in the brain, resulting in a reduction in the efficacy of peripheral cholinergic side effects. Rivastigmine in vivo half-life is short and long duration of action. Unlike tacrine, this product in the hippocampus and cortex of G1 enzyme inhibitory effect is stronger. Clinic for the treatment of mild to moderate Alzheimer-type dementia, or Alzheimer’s disease can be suspected Alzheimer’s disease clinically.
    Alzheimerdisease Alzheimer’s disease (Alzheimerdisease, AD) is a kind of onset hidden attack the development of dementia, clinical with memory disorders, aphasia, apraxia, agnosia, executive function and cognitive impairment features. Al mismo tiempo, that is accompanied by the psychological and behavioral abnormalities and obvious function of social life decline. AD duration course is 3 a 7 años, after the onset of a small number of patients can survive for more than 10 years or longer. En 1906, German neurologist Alzheimer first reported one case of 51-year-old female patient, brain autopsy found that age spots, he added that the disease has been reported neurofibrillary changes. Kraepelin (1913) would be named the disease of Alzheimer’s disease. Thought that the disease is only found in pre-elderly, it is also known as Alzheimer’s (preseniledementia). Later found brain senile dementia (seniledementia) and even the health of the elderly also have the same AD pathology, only a difference in degree. In the 1970s, the US National Institute of Gerontology Research Institute (NIA), the National neurology, language barriers and Stroke Research Institute (NINCDS) and the National Institute of Mental Health (NIMH) unified on senile dementia and AD mutual understanding of the relationship, in addition to age sooner than thought, both clinical symptoms and pathological brain changes were not significantly different, the Department of the same disease. Although the incidence of pre-elderly has been proposed, said AD2 type, is equivalent to the previous Alzheimer’s disease, old age of AD1 type, the equivalent to senile dementia, but in the new diagnostic classification of literature in general, the onset before the age of 65 said early-onset AD, después 65 años, the onset of said late onset AD; in families predisposed called familial AD (FAD), said that no family predisposed sporadic AD.
    Pharmacokinetics Absorption: Rivastigmine completely absorbed quickly. Acerca de 1 hour to reach the peak plasma concentration. Because interacts with the target enzyme, biological drugs increase using more than the increased dose is expected values of about 1.5 veces. The absolute bioavailability of taking 3 mg is about 36%. Rivastigmine with food can be allowed to absorb Tmax an extra 90 minutes to reduce the Cmax, AUC increased nearly 30%.
    Distribution: the binding capacity of Rivastigmine with plasma protein is weak (aproximadamente 40%). It easily passes the blood-brain barrier, surface volume of distribution is 1.8~2.7L/kg.
    Metabolism: Rivastigmine mainly goes through cholinesterase mediated hydrolysis and rapid, extensive metabolism (plasma half-life of about 1 hour). In vitro experiment results show that this metabolite only a weak cholinesterase inhibition (<10%). In vitro and animal experimental results show that the majority of the cytochrome P450 isoenzymes are rarely involved in rivastigmine hydrogen tartrate metabolism. In vivo experiments also confirmed the bitartrate.
    Excretion: In urine, it is not found rivastigmine hydrogen tartrate prototype drug. The main metabolites excreted through the kidneys. 14C isotope labeled rivastigmine hydrogen tartrate administered within 24 horas, most rapidly excreted by the kidneys (> 90%) and only <1% of the drug excreted in the faeces. Alzheimer’s disease patients have no body weight Rivastigmine or a metabolite accumulation.
    Elderly subjects: Despite the elderly Rivastigmine biological utilization degree is higher than that of healthy young volunteers, but after 50 a 92 years in patients with Alzheimer test results showed that the bioavailability does not change with increasing age.
    Indications Used to treat the symptoms of mild to moderate Alzheimer’s disease dementia symptoms.
    Side effects The most commonly reported adverse drug reactions were gastrointestinal reactions,, including nausea (38%), vomiting (23%), especially in the dosage of the more obvious. In clinical trials,it found that women were more prone to gastrointestinal reactions and weight loss.
    The following table lists the adverse reactions of this product, including clinical trials and post-marketing reports of all cumulative.
    Adverse reactions Frequency of occurrence
    Cardiac abnormalities
    Arrhythmia Very rare
    Angina rare
    Vascular abnormalities
    hypertension Very rare
    Gastrointestinal system disorder
    nausea Very common
    Vomit Very common
    Loss of appetite Very common
    diarrhea Very common
    Abdominal pain and indigestion common
    Gastric and duodenal ulcers rare
    Gastrointestinal bleeding Very rare
    Mild pancreatitis Very rare
    Skin and subcutaneous tissue abnormalities
    Increased sweating common
    rash rare
    General exception
    Fatigue and weakness common
    Unwell common
    Accidental fall Occasionally
    survey
    Weight loss common
    Above Pictured: The common adverse reactions of Rivastigmine in various body systems table.
    The frequency of adverse reactions were follows conversion: very common (>=1/10), common (>=1/100, <1/10), occasionally (>=1/1 000, <1/100), rare (>=1/10000, <1/1 000), very rare (<1/10000), including case reports.
    Además, the following side effects in patients taking Exelon in patients with the occurrence rate of at least a given placebo 2%, increased sweating, general malaise, weight loss, tremor. Female patients with nausea, vomiting, loss of appetite and weight loss are more sensitive. Exelon does not cause changes in any laboratory examinations, including liver function, or electrocardiogram, and there is no need special care.
    There is a case of patients taking this product, while the joint use of several other drugs, the emergence of Stevense-Johnson syndrome.
    In the initial phase of treatment, the incidence of adverse reactions is higher than the maintenance phase. In case of severe intolerable (such as severe nausea, vomiting, etc.), you should consider taking 3 veces al día.
    Pregnant and lactating women Pregnancy: Animal experiments show that rivastigmine has no teratogenic effects. Because the lack of experimental data security using this service when people pregnancy, so pregnant women using this service should be weighed the pros and cons.
    Lactation: whether the product is secreted from human milk, which is unclear. Sin embargo, in animals rivastigmine tartrate can be secreted from the milk. Patients using this service should stop breastfeeding. Accordingly, patients with ongoing breast feeding should not be using this service.
    Pediatric Children are not recommended to take this product.
    Elderly patients Although the elderly’s rivastigmine bitartrate bioavailability is higher than that of young healthy volunteers, but after 50 a 92 years in patients with Alzheimer test results show that rivastigmine tartrate bioavailability does not change with increasing age.
    Drug Interactions (1) Rivastigmine is mainly through hydrolysis cholinesterase metabolism, cytochrome P450 isozymes are rarely involved in its metabolism. Por lo tanto, the product and by other drugs metabolized by these enzymes does not exist pharmacokinetic interactions.
    (2) study in healthy volunteers found the product (a single dose of 3mg) with digoxin, warfarin, diazepam or fluoxetine, have no pharmacokinetic interactions. Warfarin induced by prothrombin time extension are not affected by this product. After combination of digoxin and the product found no adverse impact on cardiac conduction.
    (3) In clinical studies of patients with Alzheimer’s disease (AD), the goods and some commonly used prescription drugs combined, such as antacids, antiemetics, hypoglycemic agents, β-blockers, calcium channel blockers agents, inotropic agents, anti-angina drugs, non-steroidal anti-inflammatory drugs, estrogens, analgesics, tranquilizers, antihistamines, etc., and risk of clinically relevant adverse reaction does not increase
    (4) In view of the pharmacokinetic effect of this product, this product should not be used in combination with other cholinergic drugs, it may interfere with the activity of anticholinergic drugs.
    (5) There is no experience of this product with anti Parkinson drugs, anti anxiety drugs (except for stability), antipsychotic drugs, antiepileptic drugs, antidepressant drugs.
    (6) rivastigmine tartrate as a cholinesterase inhibitor, during anesthesia, it can be used to enhance succinylcholine-type muscle relaxant effect.
    Contraindicaciones It is known for rivastigmine tartrate, other carbamate derivatives or other components of the formulation in patients allergic to this ban. Severe liver failure patients with severe Rivastigmine efficacy and safety have not been studied.
    Precautions 1. As inhibitors of acetylcholinesterase, rivastigmine tartrate can improve succinylcholine-type muscle relaxant effect. Por lo tanto, before anesthesia should have the right to stop taking this interim period. The goods and other cholinergic or anti-cholinergic agents in combination, should be particularly cautious (see Drug Interactions).
    2. Due to their pharmacological effects, cholinesterase inhibitors on heart rate may produce vagal nervous effects. Like with other cholinergic drugs, when administered to sick sinus syndrome or other heart block in patients using this service, you must be more cautious (see Adverse reactions).
    3. cholinergic nerve excitability can cause gastric acid secretion. Although no evidence of corresponding symptoms worsen during the clinical trials, there is a high risk of gastric ulcer patients, such as those with a history of ulcer disease, or accept non-steroidal anti-inflammatory drugs in patients with concomitant therapy should be used with caution.
    4. Like other cholinesterase inhibitors, patients with a history of asthma or other obstructive pulmonary disease should be used with caution to rivastigmine bitartrate.
    Propiedades químicas White to Off-White Powder
    Usos A brain selective acetylcholinesterase inhibitor. Nootrópico.
    Usos Rivastigmine Tartrate, a cholinesterase inhibitor with IC50 of 5.5 μM, ues as a parasympathomimetic or cholinergic agent for the treatment of mild to moderate Alzheimer disease.
    Usos Nootrópico & Alzheimer’s treatment
    Definition ChEBI: A tartrate salt obtained by reaction of rivastigmine with one equivalent of (R,R)-tartaric acid. A reversible cholinesterase inhibitor.

    Nuestro servicio

    1.100% La política de reenvío es nuestro negocio básico. Reenvío del 100% inmediatamente si su paquete permanece en Aduana por 4 días y no se actualiza.
    2.Reembolso total por 15 días de insatisfacción con la calidad.
    3.Podemos proporcionar muestras gratis..
    4.Tenemos un embalaje especial ,Se puede pasar fácilmente por la aduana.Será más seguro..
    5.Nuestra empresa tiene una cooperación a largo plazo con DHL.EMS.Fedex y así sucesivamente. Se puede enviar a su mano más rápidamente. La foto del paquete debe ofrecerse dentro de las 12 horas posteriores a la recepción de su pago de esteroides.
    6.Si tienes la oportunidad de venir a China. Puedo mostrarte nuestro laboratorio.
    7.Nuestra empresa tiene WU, MG, TT, y formas de pago de Bitcoin por adelantado. 95% por el costo de los péptidos al principio por pedido, el resto nos lo puede ofrecer en su próximo pedido;

    Formulario de Consulta ( nos pondremos en contacto con usted lo antes posible )

    Nombre:
    *
    Correo electrónico:
    *
    Mensaje:

    Verificación:
    0 + 4 = ?

    Quizás te guste también

  • Cómo hacer un pedido?

    Elige los artículos que quieras;
    Contácteme a través del correo electrónico con su demanda;
    Se reenviará la cotización;
    Hacer el pago;
    Paquete arreglado;
    Envío arreglado.
    Se proporcionará servicio de rastreo.

  • Nuestros productos

    Polvo de esteroides crudos

    SARMS

    Péptidos

    Disolventes

    APIS

    Máquina de filtrado

    Prensa de tabletas

    Viales, caucho, tapas, cripmer

  • Envío de vajilla

    EMS

    DHL

    Fedex

    TNT

    UPS

    EUB / ETK ect.

  • Contáctenos

    Correo electrónico:rawsteroidsale@gmail.com
    ¿Qué es la aplicación?:+8618676137192
    skype : +8618676137192
    Sitio web:http://www.powerfulsteroids.com/